Killing of Mycobacterium Tuberculosis by Neutrophils: a Nonoxidative Process
Overview
Authors
Affiliations
To determine the role of oxygen radicals in the killing of Mycobacterium tuberculosis by neutrophils, the effects of free-radical inhibitors and enzymes, catalase, superoxide dismutase, taurine, deferoxamine, and histidine were evaluated. Changes in the viability of M. tuberculosis were determined by agar plate colony counts and a radiometric assay. No impairment in killing was seen with any of the inhibitors or enzymes. Patients with chronic granulomatous disease (CGD) have a defect in the NADPH oxidase pathway, causing their neutrophils to be unable to generate oxygen radicals. If these radicals are involved in killing, then CGD neutrophils should be less effective killers of M. tuberculosis than normal neutrophils. There was no evidence by either measure of M. tuberculosis viability that CGD neutrophils were less bactericidal than normal neutrophils. Killing by normal neutrophils was also effective in the absence of serum. These results lead to the conclusion that the mechanism by which M. tuberculosis is killed by neutrophils is independent of the oxygen metabolic burst.
: immune response, biomarkers, and therapeutic intervention.
Zhuang L, Yang L, Li L, Ye Z, Gong W MedComm (2020). 2024; 5(1):e419.
PMID: 38188605 PMC: 10771061. DOI: 10.1002/mco2.419.
The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease.
Alkarni M, Lipman M, Lowe D Ann Clin Microbiol Antimicrob. 2023; 22(1):14.
PMID: 36800956 PMC: 9938600. DOI: 10.1186/s12941-023-00562-6.
Gaffney E, Murphy D, Walsh A, Connolly S, Basdeo S, Keane J Front Immunol. 2022; 13:984293.
PMID: 36203565 PMC: 9531133. DOI: 10.3389/fimmu.2022.984293.
High-Dose H37rv Infection in IL-17A- and IL-17A/F-Deficient Mice.
Ritter K, Behrends J, Ruckerl D, Holscher A, Volz J, Prinz I Cells. 2022; 11(18).
PMID: 36139450 PMC: 9496946. DOI: 10.3390/cells11182875.
It Takes a Village: The Multifaceted Immune Response to Infection and Vaccine-Induced Immunity.
Larsen S, Williams B, Rais M, Coler R, Baldwin S Front Immunol. 2022; 13:840225.
PMID: 35359957 PMC: 8960931. DOI: 10.3389/fimmu.2022.840225.